Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure
- 1 May 1998
- journal article
- clinical trial
- Published by Elsevier in Life Sciences
- Vol. 62 (26) , 2425-2430
- https://doi.org/10.1016/s0024-3205(98)00225-2
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Kimura Memorial Heart Foundation
This publication has 25 references indexed in Scilit:
- Asymmetrical Dimethylarginine, an Endogenous Nitric Oxide Synthase Inhibitor, in Experimental HypertensionHypertension, 1997
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic RabbitsBiochemical and Biophysical Research Communications, 1996
- Expression of Inducible Nitric Oxide Synthase in Failing and Non-failing Human HeartJournal of Molecular and Cellular Cardiology, 1996
- Role of nitric oxide in the regulation of myocardial functionProgress in Cardiovascular Diseases, 1995
- Increased nitric oxide production in heart failureThe Lancet, 1994
- Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsiaThe Lancet, 1993
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992
- Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure.Heart, 1991
- Congestive cardiac failure: central role of the arterial blood pressure.Heart, 1987